{"organizations": [], "uuid": "47ccd929631e74ae98262643b8481f94303a5b19", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/10", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/03/pr-newswire-bruker-reports-first-quarter-2018-financial-results.html", "country": "US", "domain_rank": 767, "title": "Bruker Reports First Quarter 2018 Financial Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.027, "site_type": "news", "published": "2018-05-04T00:05:00.000+03:00", "replies_count": 0, "uuid": "47ccd929631e74ae98262643b8481f94303a5b19"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/03/pr-newswire-bruker-reports-first-quarter-2018-financial-results.html", "ord_in_thread": 0, "title": "Bruker Reports First Quarter 2018 Financial Results", "locations": [], "entities": {"persons": [{"name": "bruker", "sentiment": "none"}], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "billerica", "sentiment": "none"}], "organizations": [{"name": "bruker corporation", "sentiment": "negative"}, {"name": "bruker reports first", "sentiment": "negative"}, {"name": "bruker", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BILLERICA, Mass., May 3, 2018 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) today announced financial results for its first quarter ended March 31, 2018.\nBruker's revenues of 2018 were $431.7 million, an increase of 12.2% compared to 2017. In 2018, Bruker's year-over-year organic revenue growth was 4.0%, while the favorable effect from changes in foreign currency rates was 7.7%, and growth from acquisitions was 0.5%.\nFirst quarter 2018 GAAP operating income was $38.1 million, compared to $37.6 million in 2017. Non-GAAP operating income was $52.9 million, compared to $49.2 million in 2017. On a non-GAAP basis, Bruker's first quarter 2018 operating margin was 12.3%, compared to 12.8% in 2017. The year-over-year decline in non-GAAP operating margin was primarily attributable to a strong unfavorable impact from changes in foreign currency rates, which more than offset healthy operational margin improvement in the first quarter.\nFirst quarter 2018 GAAP diluted earnings per share (EPS) were $0.17, compared to $0.13 in 2017. First quarter 2018 non-GAAP diluted EPS were $0.24, a 26.3% increase over non-GAAP diluted EPS of $0.19 in 2017. A reconciliation of non-GAAP to GAAP financial measures is provided in the tables accompanying this press release.\nFrank Laukien, President and CEO of Bruker, commented: \"Bruker is off to a solid start in 2018 with 4% organic revenue growth and strong EPS improvement. We remain focused on our key priorities of portfolio transformation and operational excellence. With healthy end markets, organic growth improvements in our Scientific Instruments segment, and continued good operational execution in the quarter, we believe that Bruker is on track to deliver on our 2018 financial commitments.\"\nBruker's guidance for fiscal year 2018 revenue growth, non-GAAP operating margin expansion and non-GAAP EPS is unchanged.\nQuarterly Earnings Call\nBruker will host a conference call and webcast to discuss its financial results, business outlook, and related corporate and financial matters today at 4:30 p.m. Eastern Daylight Time. To listen to the webcast, investors can go to https://ir.bruker.com and click on the \"Events & Presentations\" hyperlink. A slide presentation that will be referenced during the webcast will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (US toll free) or +1-412-317-6702 (international), and referencing \"Bruker's First Quarter 2018 Earnings Conference Call\". A telephone replay of the conference call will be available by dialing 1-877-344-7529 (US toll free) or +1-412-317-0088 (international) and entering conference number: 10119735. The replay will be available beginning one hour after the end of the conference through June 3, 2018.\nAbout Bruker Corporation\nFor more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com .\nUse of Non-GAAP Financial Measures\nTo supplement our consolidated financial statements, which are prepared and presented in accordance with U.S. generally accepted accounting principles (GAAP), we use the following non-GAAP financial measures in this press release and in the earnings webcast: non-GAAP gross profit; non-GAAP gross profit margin; non-GAAP operating income; non-GAAP operating margin; non-GAAP profit before tax; non-GAAP tax rate; non-GAAP net income and non-GAAP earnings per share. These non-GAAP measures exclude costs related to restructuring actions, acquisition and related integration expenses, amortization of acquired intangible assets and other non-operational costs.\nWe also refer to organic revenue growth and free cash flow in this press release and in the earnings webcast, which are also non-GAAP financial measures. We define the term organic revenue as GAAP revenue excluding the effect of changes in foreign currency translation rates and the effect of acquisitions and divestitures, and believe it is a useful measure to evaluate our continuing business. We define free cash flow as net cash provided by operating activities less additions to property, plant, and equipment. We believe free cash flow is a useful measure to evaluate our business because it indicates the amount of cash generated after additions to property, plant, and equipment that is available for, among other things, acquisitions, investments in our business, repayment of debt and return of capital to shareholders.\nThe presentation of these non-GAAP financial measures is not intended to be a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP and may be different from non-GAAP financial measures used by other companies, and therefore, may not be comparable among companies. We believe these non-GAAP financial measures provide meaningful supplemental information regarding our performance. Specifically, management believes that the non-GAAP measures mentioned above provide relevant and useful information which is widely used by analysts, investors and competitors in our industry, as well as by our management, in assessing both consolidated and business unit performance.\nWe use these non-GAAP financial measures to evaluate our period-over-period operating performance because our management believes this provides a more comparable measure of our continuing business by adjusting for certain items that are not reflective of the underlying performance of our business. These measures may also be useful to investors in evaluating the underlying operating performance of our business and forecasting future results. We regularly use these non-GAAP financial measures internally to understand, manage, and evaluate our business results and make operating decisions. We also measure our employees and compensate them, in part, based on such non-GAAP measures and use this information for our planning and forecasting activities.\nAdditional information relating to these non-GAAP financial measures and reconciliations to the most directly comparable GAAP financial measures is provided in the tables accompanying this press release following our GAAP financial statements and in our slide presentation, which is available through the \"Bruker Earnings Release\" hyperlink on Bruker's Investor Relations web site ir.bruker.com .\nWith respect to the Company's outlook for 2018 non-GAAP operating margin, non-GAAP EPS and non-GAAP tax rate, we are not providing the most directly comparable GAAP financial measures or corresponding reconciliations to such GAAP financial measures on a forward-looking basis, because we are unable to predict with reasonable certainty certain items that may affect such measures calculated and presented in accordance with GAAP without unreasonable effort. Our expected non-GAAP operating margin, tax rate and EPS ranges exclude primarily the future impact of restructuring actions, unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments. These reconciling items are uncertain, depend on various factors outside our management's control and could significantly impact, either individually or in the aggregate, our future period operating margins, EPS and tax rate calculated and presented in accordance with GAAP.\nForward Looking Statements\nAny statements contained in this press release which do not describe historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to that could cause actual results to differ materially from those indicated, including, but not limited to, relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, fluctuations in foreign currency exchange rates, our ability to successfully implement our restructuring initiatives, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners, key suppliers and contract manufacturers, capital spending and government funding policies, changes in governmental regulations, the use and protection of intellectual property rights, litigation, and other risk factors discussed from time to time in our filings with the Securities and Exchange Commission, or SEC. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2017 and subsequently filed Quarterly Reports on Form 10-Q. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by law.\n-tables follow-\nContacts :\nMiroslava Minkova\nHead of Investor Relations\nBruker Corporation\nT: +1 (978) 663 â€“ 3660, ext. 1479\nE: miroslava.minkova@bruker.com\nBruker Corporation\nCONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)\n(in millions)\nMarch 31,\nDecember 31,\n2018\n2017\nASSETS\nCurrent assets:\nCash and cash equivalents\n$ 283.9\n$ 325.0\nShort-term investments\n-\n114.2\nAccounts receivable, net\n313.6\n319.3\nInventories\n518.0\n486.2\nOther current assets\n125.0\n114.1\nTotal current assets\n1,240.5\n1,358.8\nProperty, plant and equipment, net\n270.0\n266.5\nIntangibles, net and other long-term assets\n320.0\n323.2\nTotal assets\n$ 1,830.5\n$ 1,948.5\nLIABILITIES AND SHAREHOLDERS' EQUITY\nCurrent liabilities:\nCurrent portion of long-term debt\n$ 15.0\n$ -\nAccounts payable\n104.7\n90.8\nCustomer advances\n125.3\n111.7\nOther current liabilities\n313.7\n322.0\n558.7\n524.5\nLong-term debt\n205.6\n415.6\nOther long-term liabilities\n275.9\n274.9\nTotal shareholders' equity\n790.3\n733.5\nTotal liabilities and shareholders' equity\n$ 1,830.5\n$ 1,948.5\nBruker Corporation\nCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)\nThree Months Ended\n(in millions, except per share amounts)\nMarch 31,\n2018\n2017\nRevenues\n$ 431.7\n$ 384.9\nCost of revenues\n232.3\n208.5\nGross profit\n199.4\n176.4\nOperating expenses:\nSelling, general and administrative\n110.3\n98.1\nResearch and development\n43.2\n37.6\nOther charges, net\n7.8\n3.1\nTotal operating expenses\n161.3\n138.8\nOperating income\n38.1\n37.6\nInterest and other income (expense), net\n(2.3)\n(6.0)\nIncome before income taxes and noncontrolling\ninterest in consolidated subsidiaries\n35.8\n31.6\nIncome tax provision\n8.4\n9.9\nConsolidated net income\n27.4\n21.7\nNet income attributable to noncontrolling\ninterests in consolidated subsidiaries\n0.4\n0.1\nNet income attributable to Bruker Corporation\n$ 27.0\n$ 21.6\nNet income per common share attributable to\nBruker Corporation shareholders:\nBasic\n$ 0.17\n$ 0.14\nDiluted\n$ 0.17\n$ 0.13\nWeighted average common shares outstanding:\nBasic\n155.9\n159.7\nDiluted\n157.0\n160.5\nBruker Corporation\nCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)\nThree Months Ended\n(in millions)\nMarch 31,\n2018\n2017\nCash flows from operating activities:\nConsolidated net income\n$ 27.4\n$ 21.7\nAdjustments to reconcile consolidated net income to cash flows\nfrom operating activities:\nDepreciation and amortization\n15.8\n15.1\nStock-based compensation expense\n2.5\n2.6\nDeferred income taxes\n(7.1)\n0.4\nOther non-cash expenses, net\n18.2\n4.1\nChanges in operating assets and liabilities, net of acquisitions and divestitures:\nAccounts receivable\n10.0\n25.6\nInventories\n(32.0)\n(31.1)\nAccounts payable and accrued expenses\n(13.7)\n(2.7)\nIncome taxes payable, net\n(3.3)\n(6.4)\nDeferred revenue\n5.9\n0.9\nCustomer advances\n17.8\n(3.1)\nOther changes in operating assets and liabilities, net\n2.3\n5.5\nNet cash provided by operating activities\n43.8\n32.6\nCash flows from investing activities:\nPurchases of short-term investments\n-\n(85.3)\nMaturities of short-term investments\n117.0\n58.7\nCash paid for acquisitions, net of cash acquired\n(0.4)\n(39.8)\nPurchases of property, plant and equipment\n(8.5)\n(11.5)\nProceeds from sales of property, plant and equipment\n-\n6.6\nNet cash provided by (used in) investing activities\n108.1\n(71.3)\nCash flows from financing activities:\nProceeds from revolving lines of credit\n-\n33.0\nRepayment of revolving lines of credit\n(195.0)\n(40.0)\nRepayment of note purchase agreement\n-\n(20.0)\nRepayment of other debt, net\n(0.1)\n(0.1)\nProceeds from issuance of common stock, net\n2.6\n1.2\nPayment of dividends\n(6.3)\n(6.4)\nNet cash used in financing activities\n(198.8)\n(32.3)\nEffect of exchange rate changes on cash, cash equivalents and restricted cash\n5.8\n5.8\nNet change in cash, cash equivalents and restricted cash\n(41.1)\n(65.2)\nCash, cash equivalents and restricted cash at beginning of period\n328.9\n345.9\nCash, cash equivalents and restricted cash at end of period\n$ 287.8\n$ 280.7\nBruker Corporation\nRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (unaudited)\n(in millions, except per share amounts)\nThree Months Ended March 31,\n2018\n2017\nReconciliation of Non-GAAP Operating Income, Non-GAAP Profit\nBefore Tax, Non-GAAP Net Income, and Non-GAAP EPS\nGAAP Operating Income\n$ 38.1\n$ 37.6\nNon-GAAP Adjustments:\nRestructuring Costs\n3.5\n0.1\nAcquisition-Related Costs\n1.0\n2.8\nPurchased Intangible Amortization\n6.8\n6.9\nOther Costs\n3.5\n1.8\nTotal Non-GAAP Adjustments:\n$ 14.8\n$ 11.6\nNon-GAAP Operating Income\n$ 52.9\n$ 49.2\nNon-GAAP Operating Margin\n12.3%\n12.8%\nNon-GAAP Interest & Other Expense, net\n(2.3)\n(6.0)\nNon-GAAP Profit Before Tax\n50.6\n43.2\nNon-GAAP Income Tax Provision\n(12.0)\n(13.2)\nNon-GAAP Tax Rate\n23.7%\n30.6%\nMinority Interest\n(0.4)\n(0.1)\nNon-GAAP Net Income Attributable to Bruker\n38.2\n29.9\nWeighted Average Shares Outstanding (Diluted)\n157.0\n160.5\nNon-GAAP Earnings Per Share\n$ 0.24\n$ 0.19\nReconciliation of GAAP and Non-GAAP Gross Profit\nGAAP Gross Profit\n$ 199.4\n$ 176.4\nNon-GAAP Adjustments:\nRestructuring Costs\n0.2\n(1.4)\nAcquisition-Related Costs\n-\n2.5\nPurchased Intangible Amortization\n5.4\n5.4\nOther Costs\n-\n0.5\nTotal Non-GAAP Adjustments:\n5.6\n7.0\nNon-GAAP Gross Profit\n$ 205.0\n$ 183.4\nNon-GAAP Gross Margin\n47.5%\n47.6%\nReconciliation of GAAP and Non-GAAP Tax Rate\nGAAP Tax Rate\n23.5%\n31.3%\nNon-GAAP Adjustments:\nTax Impact of Non-GAAP Adjustments\n-0.3%\n0.6%\nTax Authority Settlements\n0.0%\n0.3%\nOther Discrete Items\n0.5%\n-1.6%\nTotal Non-GAAP Adjustments:\n0.2%\n-0.7%\nNon-GAAP Tax Rate\n23.7%\n30.6%\nReconciliation of GAAP and Non-GAAP Earnings Per Share (Diluted)\nGAAP Earnings Per Share (Diluted)\n$ 0.17\n$ 0.13\nNon-GAAP Adjustments:\nRestructuring Costs\n0.02\n-\nAcquisition-Related Costs\n0.01\n0.02\nPurchased Intangible Amortization\n0.04\n0.04\nOther Costs\n0.02\n0.02\nBargain Purchase Gain\n-\n-\nIncome Tax Rate Differential\n(0.02)\n(0.02)\nTotal Non-GAAP Adjustments:\n0.07\n0.06\nNon-GAAP Earnings Per Share (Diluted)\n$ 0.24\n$ 0.19\nReconciliation of GAAP Operating Cash Flow and Non-GAAP Free Cash Flow\nGAAP Operating Cash Flow\n$ 43.8\n$ 32.6\nNon-GAAP Adjustments:\nPurchases of property, plant and equipment\n(8.5)\n(11.5)\nNon-GAAP Free Cash Flow\n$ 35.3\n$ 21.1\nBruker Corporation\nREVENUE (unaudited)\n(in millions)\nThree Months Ended March 31,\n2018\n2017\nRevenue by Group:\nBruker BioSpin\n$ 131.8\n$ 125.2\nBruker CALID\n131.3\n110.5\nBruker Nano\n123.9\n110.7\nBEST\n45.6\n40.1\nEliminations\n(0.9)\n(1.6)\nTotal Revenue\n$ 431.7\n$ 384.9\nRevenue by End Customer Geography:\nUnited States\n$ 104.8\n$ 96.1\nEurope\n161.4\n130.0\nAsia Pacific\n126.9\n125.6\nOther\n38.6\n33.2\nTotal Revenue\n$ 431.7\n$ 384.9\nReconciliation of GAAP Reported Revenue Growth to Organic Revenue Growth\nGAAP Revenue as of Prior Comparable Period\n$ 384.9\n$ 375.4\nNon-GAAP Adjustments:\nAcquisitions and divestitures\n2.0\n19.7\nCurrency\n29.5\n(7.3)\nOrganic\n15.3\n(2.9)\nTotal Non-GAAP Adjustments:\n46.8\n9.5\nNon-GAAP Revenue\n$ 431.7\n$ 384.9\nOrganic Revenue Growth\n4.0%\n-0.8%\nThe Company adopted Accounting Standards Codification (ASC) 606 as of January 1, 2018 under the modified retrospective approach. Accordingly, the 2017 revenue amounts have not been restated to reflect ASC 606 and are presented for informational purposes only. The adoption of ASC 606 was not material for the period ended March 31, 2018.\nView original content with multimedia: http://www.prnewswire.com/news-releases/bruker-reports-first-quarter-2018-financial-results-300642478.html\nSOURCE Bruker Corporation", "external_links": ["http://www.bruker.com/", "http://www.prnewswire.com/news-releases/bruker-reports-first-quarter-2018-financial-results-300642478.html", "https://ir.bruker.com/"], "published": "2018-05-04T00:05:00.000+03:00", "crawled": "2018-05-04T03:19:37.005+03:00", "highlightTitle": ""}